نتایج جستجو برای: cgvhd

تعداد نتایج: 422  

Journal: :The journal of supportive oncology 2008
Richard W Joseph Daniel R Couriel Krishna V Komanduri

Chronic GVHD (cGVHD) remains one of the most significant complications affecting the quality of life of long-term survivors of allogeneic stem cell transplant (SCT). Recent advancements in SCT, including the adoption of reduced-intensity conditioning regimens and improvements in inpatient supportive care, have yielded dramatic reductions in early mortality and led to the expanding use of alloge...

2013
Philipp Eberwein Susanne Issleib Daniel Böhringer Hans Mittelviefhaus Johannes Schwartzkopff Juergen Finke Thomas Reinhard

PURPOSE To assess the expression of human leucocyte antigen (HLA)-DR in epithelial cells and cluster of differentiation (CD8)-positive lymphocytes as possible markers of chronic ocular graft versus host disease (cGvHD) after hematological stem cell transplantation (HSCT). METHODS Twenty-seven consecutive patients with dry-eye symptoms following HSCT (24 [89%] with peripheral blood stem cell t...

2016
Mašenjka Katić Filip Pirsl Seth M. Steinberg Marnie Dobbin Lauren M. Curtis Dražen Pulanić Lana Desnica Irina Titarenko Steven Z. Pavletic

AIM To identify the factors associated with vitamin D status in patients with chronic graft-vs-host disease (cGVHD) and evaluate the association between serum vitamin D (25(OH)D) levels and cGVHD characteristics and clinical outcomes defined by the National Institutes of Health (NIH) criteria. METHODS 310 cGVHD patients enrolled in the NIH cGVHD natural history study (clinicaltrials.gov: NCT0...

2013
Masahiro Hirayama Eiichi Azuma Shotaro Iwamoto Keishiro Amano Atsuko Nakazawa Shigehisa Tamaki Eiji Usui Yoshihiro Komada

To the Editor: Chronic graft-versus-host disease (cGVHD) is a major cause of morbidity and mortality in patients after allogeneic hematopoietic stem cell transplantation (HSCT) (1, 2). ‘Trial-and-error system’ remains the only way to identify the effectiveness of immunosuppressive drug in the individual patient, and valid biomarkers for cGVHD are eagerly needed to identify the response to the d...

Journal: :Journal of Investigative Dermatology 2023

Cutaneous manifestations are the most common presenting sign of chronic graft-versus-host disease (cGVHD) and extent cutaneous involvement is also highly correlated with prognosis. Very little understood about underlying pathogenesis underpinning injury at this location, especially contribution keratinocytes other structural skin cells. We performed single-cell RNA-sequencing to compare transcr...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2015
Michael Boyiadzis Mukta Arora John P Klein Anna Hassebroek Michael Hemmer Alvaro Urbano-Ispizua Joseph H Antin Brian J Bolwell Jean-Yves Y Cahn Mitchell S Cairo Corey S Cutler Mary E Flowers Robert P Gale Roger Herzig Luis M Isola David A Jacobsohn Madan H Jagasia Thomas R Klumpp Stephanie J Lee Effie W Petersdorf Stella Santarone Stephen R Spellman Harry C Schouten Leo F Verdonck John R Wingard Daniel J Weisdorf Mary M Horowitz Steven Z Pavletic

PURPOSE Malignancy relapse remains a major obstacle for successful allogeneic hematopoietic cell transplantation (HCT). Chronic graft-versus-host disease (cGVHD) is associated with fewer relapses. However, when studying effects of cGVHD on relapse, it is difficult to separate from acute GVHD effects as most cases of cGVHD occur within the first year after transplant at the time when acute GVHD ...

Journal: :Haematologica 1997
A Urbano-Ispizua J García-Conde S Brunet F Hernández G Sanz J Petit J Bargay A Figuera M Rovira C Solano E Ojeda J de la Rubia C Rozman

BACKGROUND AND OBJECTIVE The incidence of acute GVHD (aGVHD) in allogeneic peripheral blood progenitor cell transplantation (allo-PBPCT) seems to be similar to that seen in allogeneic bone marrow transplantation (allo-BMT). In contrast, some preliminary results suggest that the incidence of chronic GVHD (cGVHD) might be higher. The aim of the present study was to analyze the actuarial probabili...

2016
Gilles Fransolet Grégory Ehx Joan Somja Loïc Delens Muriel Hannon Joséphine Muller Sophie Dubois Pierre Drion Jo Caers Stéphanie Humblet-Baron Philippe Delvenne Yves Beguin Giuseppina Conteduca Frédéric Baron

BACKGROUND Previous studies have demonstrated that regulatory T cells (Tregs) play a protective role in the pathogenesis of chronic graft-versus-host disease (cGVHD). Tregs constitutively express the gene of the transcription factor Foxp3 whose CNS2 region is heavily methylated in conventional CD4(+) T cells (CD4(+)Tconvs) but demethylated in Tregs. METHODS Here, we assessed the impact of aza...

2011
Chang-Ki Min

Chronic graft-versus-host disease (CGVHD) is one of the most significant complications of long-term survivors after allogeneic hematopoietic stem cell transplantation (allo-HSCT). CGVHD may have protean manifestations and can pose unique diagnostic and therapeutic challenges. New recommendations that emphasize the importance of qualitative differences, as opposed to time of onset after HSCT, ar...

2014
Yehuda Zadik Itai Zeevi Noa Luboshitz-Shon Nasri Dakwar Andy Wolff Michael Y. Shapira Reuven Or Sharon Elad

OBJECTIVES Patients with chronic graft-versus-host disease (cGVHD) often suffer from dry mouth and oral mucosal lesions. The primary objective of this study was to investigate the safety of an intra-oral electrostimulator (GenNarino) in symptomatic cGVHD patients. The secondary objective was to study the impact on the salivary gland involvement of cGVHD patients. STUDY DESIGN This paper prese...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید